In a mouse model of melanoma, the combination of the tryptophan analog 1-methyl-D-tryptophan plus an antitumor vaccine caused conversion of Tregs to the Th17, with marked enhancement of CD8+ T cell activation and antitumor efficacy (88). This evidence concerns the gene CD8A and melanoma.